Jacob Stephen Thomas

Jacob Stephen Thomas is an Assistant Professor of Clinical Medicine at the University of Southern California (USC) and serves as the Service Chief of LAC+USC Oncology. His clinical and research work focuses on oncology, including targeted therapies, cancer epidemiology, and molecular profiling. He practices at a major academic medical institution in Los Angeles, where he contributes to clinical care and translational research.

His research spans multiple cancer subfields, including non-small cell lung cancer, melanoma, and head and neck cancers. He investigates biomarkers like platelet-lymphocyte ratios and genetic alterations (e.g., ALK, EGFR) in cancer progression. His recent work explores precision oncology, such as Cyclin-dependent Kinase 9 inhibitors (KB-0742), and health disparities in Hispanic populations with thyroid and lung cancers.

His publication record includes clinical trials, case reports, and epidemiological analyses on therapeutic responses (e.g., pembrolizumab, talimogene laherparepvec) and molecular differences between primary and metastatic melanoma. His work bridges bench-to-bedside research, emphasizing real-world treatment outcomes and novel cancer therapies.

No scientific awards were explicitly mentioned in the provided text.